Via Crescentino
Saluggia, VC 13040
Italy
39 01 614871
https://diasoringroup.com/en
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 3,278
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Carlo Rosa | CEO, GM & Exec. Director | 1.75M | N/A | 1966 |
Dr. Chen Menachem Even | Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director | 857.25k | N/A | 1963 |
Mr. Piergiorgio Pedron | Sr. Corp. VP, CFO & Corp. Accounting Documents Officer | N/A | N/A | 1971 |
Mr. Fabrizio Piercarlo Bonelli | Corp. VP & Chief Technology Officer | N/A | N/A | N/A |
Dr. Riccardo Fava | Corp. VP of Communication & Investor Relations | N/A | N/A | N/A |
Mr. Ulisse Spada | Corp. VP, Head of the Legal Department, Sec. & Gen. Counsel | N/A | N/A | N/A |
Mr. Stefano Ronchi | Sr. Corp. VP of HR | N/A | N/A | 1960 |
Mr. Ugo Gay | Chief Exec. Officer of DiaSorin Italia S.p.A. | N/A | N/A | 1965 |
Mr. Angelo Rago | Pres of Luminex Corp. | N/A | N/A | 1963 |
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
DiaSorin S.p.A.’s ISS governance QualityScore as of 1 October 2023 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 8; Compensation: 10.